Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2009 entries
Sorted by: Best Match Show Resources per page
Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits.

International journal of ophthalmology

Pei C, Xu Y, Jiang JX, Cui LJ, Li L, Qin L.
PMID: 23550193
Int J Ophthalmol. 2013;6(1):1-7. doi: 10.3980/j.issn.2222-3959.2013.01.01. Epub 2013 Feb 18.

AIM: To explore the inhibitory effect of a sustained cyclosporin A (CsA) delivery microsphere (CsA-MS) on posterior capsular opacification (PCO) in rabbit eyes after cataract extraction.METHODS: Twenty New Zealand white rabbits accepted cataract extraction plus intraocular lens implantation and...

Cite
Pei C, Xu Y, Jiang JX, et al. Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits. Int J Ophthalmol. 2013;6(1):1-7doi: 10.3980/j.issn.2222-3959.2013.01.01.
Pei, C., Xu, Y., Jiang, J. X., Cui, L. J., Li, L., & Qin, L. (2013). Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits. International journal of ophthalmology, 6(1), 1-7. https://doi.org/10.3980/j.issn.2222-3959.2013.01.01
Pei, Cheng, et al. "Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits." International journal of ophthalmology vol. 6,1 (2013): 1-7. doi: https://doi.org/10.3980/j.issn.2222-3959.2013.01.01
Pei C, Xu Y, Jiang JX, Cui LJ, Li L, Qin L. Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits. Int J Ophthalmol. 2013;6(1):1-7. doi: 10.3980/j.issn.2222-3959.2013.01.01. Epub 2013 Feb 18. PMID: 23550193; PMCID: PMC3580240.
Copy Download .nbib Format: NLM
Pre-treatment considerations in childhood hypertension due to chronic kidney disease.

World journal of nephrology

Olowu WA.
PMID: 26558187
World J Nephrol. 2015 Nov 06;4(5):500-10. doi: 10.5527/wjn.v4.i5.500.

Hypertension (HTN) develops very early in childhood chronic kidney disease (CKD). It is linked with rapid progression of kidney disease, increased morbidity and mortality hence the imperative to start anti-hypertensive medication when blood pressure (BP) is persistently > 90(th)...

Cite
Olowu WA. Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol. 2015;4(5):500-10doi: 10.5527/wjn.v4.i5.500.
Olowu, W. A. (2015). Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World journal of nephrology, 4(5), 500-10. https://doi.org/10.5527/wjn.v4.i5.500
Olowu, Wasiu Adekunle. "Pre-treatment considerations in childhood hypertension due to chronic kidney disease." World journal of nephrology vol. 4,5 (2015): 500-10. doi: https://doi.org/10.5527/wjn.v4.i5.500
Olowu WA. Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol. 2015 Nov 06;4(5):500-10. doi: 10.5527/wjn.v4.i5.500. PMID: 26558187; PMCID: PMC4635370.
Copy Download .nbib Format: NLM
Medical Therapy of Active Ulcerative Colitis.

Viszeralmedizin

Bürger M, Schmidt C, Teich N, Stallmach A.
PMID: 26557831
Viszeralmedizin. 2015 Aug;31(4):236-45. doi: 10.1159/000436959. Epub 2015 Aug 04.

BACKGROUND: Medical therapy of mild and moderate ulcerative colitis (UC) of any extent is evidence-based and standardized by national and international guidelines. However, patients with steroid-refractory UC still represent a challenge.METHODS: A literature search using PubMed (search terms: ulcerative...

Cite
Bürger M, Schmidt C, Teich N, et al. Medical Therapy of Active Ulcerative Colitis. Viszeralmedizin. 2015;31(4):236-45doi: 10.1159/000436959.
Bürger, M., Schmidt, C., Teich, N., & Stallmach, A. (2015). Medical Therapy of Active Ulcerative Colitis. Viszeralmedizin, 31(4), 236-45. https://doi.org/10.1159/000436959
Bürger, Martin, et al. "Medical Therapy of Active Ulcerative Colitis." Viszeralmedizin vol. 31,4 (2015): 236-45. doi: https://doi.org/10.1159/000436959
Bürger M, Schmidt C, Teich N, Stallmach A. Medical Therapy of Active Ulcerative Colitis. Viszeralmedizin. 2015 Aug;31(4):236-45. doi: 10.1159/000436959. Epub 2015 Aug 04. PMID: 26557831; PMCID: PMC4608602.
Copy Download .nbib Format: NLM
Importance of Accurate Diagnosis in Pyoderma Gangrenosum.

Archives of craniofacial surgery

Kim YS, Kim HK, Han YS.
PMID: 28913208
Arch Craniofac Surg. 2014 Dec;15(3):138-141. doi: 10.7181/acfs.2014.15.3.138. Epub 2014 Dec 23.

Pyoderma gangrenosum is a rare inflammatory reactive dermatosis marked by painful cutaneous ulcers. Diagnosis of pyoderma gangrenosum is usually made based on past medical history and after the exclusion of other possible diseases based on the clinical manifestations of...

Cite
Kim YS, Kim HK, Han YS. Importance of Accurate Diagnosis in Pyoderma Gangrenosum. Arch Craniofac Surg. 2014;15(3):138-141doi: 10.7181/acfs.2014.15.3.138.
Kim, Y. S., Kim, H. K., & Han, Y. S. (2014). Importance of Accurate Diagnosis in Pyoderma Gangrenosum. Archives of craniofacial surgery, 15(3), 138-141. https://doi.org/10.7181/acfs.2014.15.3.138
Kim, Yoon Soo, et al. "Importance of Accurate Diagnosis in Pyoderma Gangrenosum." Archives of craniofacial surgery vol. 15,3 (2014): 138-141. doi: https://doi.org/10.7181/acfs.2014.15.3.138
Kim YS, Kim HK, Han YS. Importance of Accurate Diagnosis in Pyoderma Gangrenosum. Arch Craniofac Surg. 2014 Dec;15(3):138-141. doi: 10.7181/acfs.2014.15.3.138. Epub 2014 Dec 23. PMID: 28913208; PMCID: PMC5556732.
Copy Download .nbib Format: NLM
From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Therapeutic advances in hematology

Gill H, Wong RSM, Kwong YL.
PMID: 28473904
Ther Adv Hematol. 2017 May;8(5):159-174. doi: 10.1177/2040620717693573. Epub 2017 Feb 01.

Thrombopoietin (TPO) is the most potent cytokine stimulating thrombopoiesis. Therapy with exogenous TPO is limited by the formation of antibodies cross-reacting with endogenous TPO. Mimetics of TPO are compounds with no antigenic similarity to TPO. Eltrombopag is an orally-active...

Cite
Gill H, Wong RSM, Kwong YL. From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Ther Adv Hematol. 2017;8(5):159-174doi: 10.1177/2040620717693573.
Gill, H., Wong, R. S. M., & Kwong, Y. L. (2017). From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Therapeutic advances in hematology, 8(5), 159-174. https://doi.org/10.1177/2040620717693573
Gill, Harinder, et al. "From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag." Therapeutic advances in hematology vol. 8,5 (2017): 159-174. doi: https://doi.org/10.1177/2040620717693573
Gill H, Wong RSM, Kwong YL. From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Ther Adv Hematol. 2017 May;8(5):159-174. doi: 10.1177/2040620717693573. Epub 2017 Feb 01. PMID: 28473904; PMCID: PMC5407506.
Copy Download .nbib Format: NLM
Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

Allergy, asthma & immunology research

Kaplan AP.
PMID: 28913986
Allergy Asthma Immunol Res. 2017 Nov;9(6):477-482. doi: 10.4168/aair.2017.9.6.477.

The treatment of chronic spontaneous urticaria begins with antihistamines; however, the dose required typically exceeds that recommended for allergic rhinitis. Second-generation, relatively non-sedating H₁-receptor blockers are typically employed up to 4 times a day. First-generation antihistamines, such as hydroxyzine...

Cite
Kaplan AP. Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. Allergy Asthma Immunol Res. 2017;9(6):477-482doi: 10.4168/aair.2017.9.6.477.
Kaplan, A. P. (2017). Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. Allergy, asthma & immunology research, 9(6), 477-482. https://doi.org/10.4168/aair.2017.9.6.477
Kaplan, Allen P. "Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations." Allergy, asthma & immunology research vol. 9,6 (2017): 477-482. doi: https://doi.org/10.4168/aair.2017.9.6.477
Kaplan AP. Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. Allergy Asthma Immunol Res. 2017 Nov;9(6):477-482. doi: 10.4168/aair.2017.9.6.477. PMID: 28913986; PMCID: PMC5603475.
Copy Download .nbib Format: NLM
The Relationship between Mortality of Lung Transplant Recipients and Serum Cyclosporine Levels: Joint Modeling of Time-to-Event Data and Longitudinal Data.

International journal of organ transplantation medicine

Hosseini-Baharanchi FS, Hajizadeh E, Baghestani AR, Najafzadeh K.
PMID: 28924464
Int J Organ Transplant Med. 2017;8(3):157-163. Epub 2017 Aug 01.

BACKGROUND: Lung transplantation (LTx) is a well-accepted treatment that can prolong survival of patients with advanced lung disease.OBJECTIVE: To evaluate the association between serum cyclosporine level (SCL) pattern and mortality of LTx recipients.METHODS: This retrospective cohort study included 1019...

Cite
Hosseini-Baharanchi FS, Hajizadeh E, Baghestani AR, et al. The Relationship between Mortality of Lung Transplant Recipients and Serum Cyclosporine Levels: Joint Modeling of Time-to-Event Data and Longitudinal Data. Int J Organ Transplant Med. 2017;8(3):157-163
Hosseini-Baharanchi, F. S., Hajizadeh, E., Baghestani, A. R., & Najafzadeh, K. (2017). The Relationship between Mortality of Lung Transplant Recipients and Serum Cyclosporine Levels: Joint Modeling of Time-to-Event Data and Longitudinal Data. International journal of organ transplantation medicine, 8(3), 157-163.
Hosseini-Baharanchi, F S, et al. "The Relationship between Mortality of Lung Transplant Recipients and Serum Cyclosporine Levels: Joint Modeling of Time-to-Event Data and Longitudinal Data." International journal of organ transplantation medicine vol. 8,3 (2017): 157-163.
Hosseini-Baharanchi FS, Hajizadeh E, Baghestani AR, Najafzadeh K. The Relationship between Mortality of Lung Transplant Recipients and Serum Cyclosporine Levels: Joint Modeling of Time-to-Event Data and Longitudinal Data. Int J Organ Transplant Med. 2017;8(3):157-163. Epub 2017 Aug 01. PMID: 28924464; PMCID: PMC5592103.
Copy Download .nbib Format: NLM
Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients.

American journal of translational research

Jacobs-Cachá C, Torres IB, López-Hellín J, Cantarell C, Azancot MA, Román A, Moreso F, Serón D, Meseguer A, Sarró E.
PMID: 28979691
Am J Transl Res. 2017 Sep 15;9(9):4173-4183. eCollection 2017.

Immunosuppression based on calcineurin inhibitors (CNIs) has greatly improved organ transplantation, although subsequent nephrotoxicity significantly hinders treatment success. There are no currently available specific soluble biomarkers for CNI-induced nephrotoxicity and diagnosis relies on renal biopsy, which is costly, invasive...

Cite
Jacobs-Cachá C, Torres IB, López-Hellín J, et al. Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients. Am J Transl Res. 2017;9(9):4173-4183
Jacobs-Cachá, C., Torres, I. B., López-Hellín, J., Cantarell, C., Azancot, M. A., Román, A., Moreso, F., Serón, D., Meseguer, A., & Sarró, E. (2017). Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients. American journal of translational research, 9(9), 4173-4183.
Jacobs-Cachá, Conxita, et al. "Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients." American journal of translational research vol. 9,9 (2017): 4173-4183.
Jacobs-Cachá C, Torres IB, López-Hellín J, Cantarell C, Azancot MA, Román A, Moreso F, Serón D, Meseguer A, Sarró E. Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients. Am J Transl Res. 2017 Sep 15;9(9):4173-4183. eCollection 2017. PMID: 28979691; PMCID: PMC5622260.
Copy Download .nbib Format: NLM
The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy.

Journal of pharmacology & pharmacotherapeutics

Patel L, Thaker A.
PMID: 26311998
J Pharmacol Pharmacother. 2015 Jul-Sep;6(3):147-53. doi: 10.4103/0976-500X.162014.

INTRODUCTION: To investigate the actions of adenosine A2B receptor modulators on VEGF and NO levels in CsA nephropathy.MATERIALS AND METHODS: Nephropathy was induced by administrating 25 mg/kg (s.c) of CsA for 5 weeks. The VEGF and NO levels were...

Cite
Patel L, Thaker A. The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy. J Pharmacol Pharmacother. 2015;6(3):147-53doi: 10.4103/0976-500X.162014.
Patel, L., & Thaker, A. (2015). The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy. Journal of pharmacology & pharmacotherapeutics, 6(3), 147-53. https://doi.org/10.4103/0976-500X.162014
Patel, Leena, and Thaker, Aswin. "The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy." Journal of pharmacology & pharmacotherapeutics vol. 6,3 (2015): 147-53. doi: https://doi.org/10.4103/0976-500X.162014
Patel L, Thaker A. The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy. J Pharmacol Pharmacother. 2015 Jul-Sep;6(3):147-53. doi: 10.4103/0976-500X.162014. PMID: 26311998; PMCID: PMC4544136.
Copy Download .nbib Format: NLM
Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?.

Journal of anesthesia

Takita K, Goda Y, Kemmotsu O, Okuyama A, Ito T, Sakamoto H, Mashio H, Kawahigashi H.
PMID: 28921224
J Anesth. 1995 Sep;9(3):239-242. doi: 10.1007/BF02479871.

The duration of action of vecuronium was tested in 41 surgical patients to evaluate whether cyclosporine modulates the action of vecuronium. The patients were divided into three groups: 12 patients with normal renal function (group A); 14 renal transplant...

Cite
Takita K, Goda Y, Kemmotsu O, et al. Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?. J Anesth. 1995;9(3):239-242doi: 10.1007/BF02479871.
Takita, K., Goda, Y., Kemmotsu, O., Okuyama, A., Ito, T., Sakamoto, H., Mashio, H., & Kawahigashi, H. (1995). Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?. Journal of anesthesia, 9(3), 239-242. https://doi.org/10.1007/BF02479871
Takita, Koichi, et al. "Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?." Journal of anesthesia vol. 9,3 (1995): 239-242. doi: https://doi.org/10.1007/BF02479871
Takita K, Goda Y, Kemmotsu O, Okuyama A, Ito T, Sakamoto H, Mashio H, Kawahigashi H. Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?. J Anesth. 1995 Sep;9(3):239-242. doi: 10.1007/BF02479871. PMID: 28921224.
Copy Download .nbib Format: NLM
A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine.

Indian journal of dermatology

Ardeshna KP, Someshwar S, Rohatgi S, Jerajani HR.
PMID: 28979024
Indian J Dermatol. 2017 Sep-Oct;62(5):537-538. doi: 10.4103/ijd.IJD_749_16.

No abstract available.

Cite
Ardeshna KP, Someshwar S, Rohatgi S, et al. A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine. Indian J Dermatol. 2017;62(5):537-538doi: 10.4103/ijd.IJD_749_16.
Ardeshna, K. P., Someshwar, S., Rohatgi, S., & Jerajani, H. R. (2017). A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine. Indian journal of dermatology, 62(5), 537-538. https://doi.org/10.4103/ijd.IJD_749_16
Ardeshna, Kenit P, et al. "A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine." Indian journal of dermatology vol. 62,5 (2017): 537-538. doi: https://doi.org/10.4103/ijd.IJD_749_16
Ardeshna KP, Someshwar S, Rohatgi S, Jerajani HR. A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine. Indian J Dermatol. 2017 Sep-Oct;62(5):537-538. doi: 10.4103/ijd.IJD_749_16. PMID: 28979024; PMCID: PMC5618849.
Copy Download .nbib Format: NLM
Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab.

Auto- immunity highlights

Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E, Fabro C, Quartuccio L, Mazzolini S, Curcio F, Tonutti E.
PMID: 26000112
Auto Immun Highlights. 2010 Nov 04;1(2):87-94. doi: 10.1007/s13317-010-0013-5. eCollection 2010 Nov.

Rheumatoid arthritis (RA) is characterized by the presence of circulating rheumatoid factor (RF) and anticitrullinated peptide antibodies (ACPA), which are positive in about 70-80% of patients. APCA have a higher specificity and therefore a higher diagnostic power than RF,...

Cite
Fabris M, De Vita S, Blasone N, et al. Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto Immun Highlights. 2010;1(2):87-94doi: 10.1007/s13317-010-0013-5.
Fabris, M., De Vita, S., Blasone, N., Visentini, D., Pezzarini, E., Pontarini, E., Fabro, C., Quartuccio, L., Mazzolini, S., Curcio, F., & Tonutti, E. (2010). Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto- immunity highlights, 1(2), 87-94. https://doi.org/10.1007/s13317-010-0013-5
Fabris, Martina, et al. "Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab." Auto- immunity highlights vol. 1,2 (2010): 87-94. doi: https://doi.org/10.1007/s13317-010-0013-5
Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E, Fabro C, Quartuccio L, Mazzolini S, Curcio F, Tonutti E. Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto Immun Highlights. 2010 Nov 04;1(2):87-94. doi: 10.1007/s13317-010-0013-5. eCollection 2010 Nov. PMID: 26000112; PMCID: PMC4389048.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2009 entries